Home › Opioid Overdose › Minnesota › Minneapolis
Opioid Overdose clinical trials in Minneapolis, MN
5 studies for Opioid Overdose are looking for participants at sites in and around Minneapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
Recruiting
- Clinic Site C (blinded pending tribal approval), Minneapolis
Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.
RecruitingPhase 4
- Hennepin Healthcare Addiction Medicine, Minneapolis
EMS-Initiated Buprenorphine
RecruitingObservational study
- Hennepin Healthcare, Minneapolis
Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder
RecruitingPhase 1
- University of Minnesota, Minneapolis
Brain Training for Substance Use Disorders
RecruitingHealthy volunteers welcome
- University of Minnesota - Department of Psychiatry & Behavioral Health, Minneapolis
About Opioid Overdose
Opioid overdose leads to slowing or stopping of breathing and sometimes death. You can take steps to help prevent an overdose, and respond to one with naloxone.
More about Opioid Overdose on MedlinePlus
Opioid Overdose trials in other cities
- Baltimore, MD18 studies
- New Haven, CT18 studies
- Philadelphia, PA15 studies
- Boston, MA12 studies
- New York City, NY12 studies
- Birmingham, AL7 studies
- Salt Lake City, UT7 studies
- Pittsburgh, PA7 studies
- Providence, RI6 studies
- San Francisco, CA6 studies
- Charleston, SC6 studies
- Indianapolis, IN5 studies
Other studies in Minneapolis
- Breast Cancer27 studies
- Non-Small Cell Lung Cancer26 studies
- Ovarian Cancer24 studies
- Prostate Cancer23 studies
- Cancer (all types)22 studies
- Heart Failure21 studies
- Lung Cancer20 studies
- Acute Myeloid Leukemia20 studies
- Colorectal Cancer19 studies
- Endometrial Cancer18 studies
- Parkinson's Disease17 studies
- Cardiovascular Disease15 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.